Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Clinical trial NCT04645212 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04645212
Sponsor: Adverum Biotechnologies, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Wet Age-related Macular Degeneration Neovascular Age-related Macular Degeneration

Start date: 2020-12-14
Primary completion: 2030-06-26
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.